| History and progression of Fat cadherins in health and disease X Zhang, J Liu, X Liang, J Chen, J Hong, L Li, Q He, X Cai OncoTargets and therapy, 7337-7343, 2016 | 46 | 2016 |
| Maturity of associating liver partition and portal vein ligation for staged hepatectomy-derived liver regeneration in a rat model YF Tong, N Meng, MQ Chen, HN Ying, M Xu, B Lu, JJ Hong, YF Wang, ... World journal of gastroenterology 24 (10), 1107, 2018 | 16 | 2018 |
| The clinical risk factors associated with postoperative bile leakage after hepatectomy: a meta-analysis. J Hong, X Zhang, R Luo, X Cai Minerva Medica 107 (1), 39-53, 2016 | 14 | 2016 |
| iPS-derived neural stem cells for disease modeling and evaluation of therapeutics for mucopolysaccharidosis type II J Hong, YS Cheng, S Yang, M Swaroop, M Xu, J Beers, J Zou, W Huang, ... Experimental cell research 412 (1), 113007, 2022 | 8 | 2022 |
| Modeling CNS involvement in Pompe disease using neural stem cells generated from patient-derived induced pluripotent stem cells YS Cheng, S Yang, J Hong, R Li, J Beers, J Zou, W Huang, W Zheng Cells 10 (1), 8, 2020 | 7 | 2020 |
| Evolution of immunotherapy for ovarian cancer from a bird’s-eye perspective: A text-mining analysis of publication trends and topics G Jiang, J Hong, F Shao, Q Wen, F Cheng, T Yu, J Zhu Frontiers in Oncology 12, 795129, 2022 | 6 | 2022 |
| Generation of an induced pluripotent stem cell line (TRNDi008-A) from a Hunter syndrome patient carrying a hemizygous 208insC mutation in the IDS gene J Hong, M Xu, R Li, YS Cheng, J Kouznetsova, J Beers, C Liu, J Zou, ... Stem cell research 37, 101451, 2019 | 5 | 2019 |
| Jejunojejunal intussusception after Roux-en-Y gastric bypass in a situs inversus totalis patient: A case report G Jiang, B Fu, S Lv, J Hong, X Cai Medicine 96 (15), e6589, 2017 | 5 | 2017 |
| Glycolysis regulation in tumor-associated macrophages: Its role in tumor development and cancer treatment JZ G Jiang, J Hong, L Sun, H Wei, W Gong, S Wang International Journal of Cancer, 2023 | 4* | 2023 |
| An induced pluripotent stem cell line (TRNDi010-C) from a patient carrying a homozygous p. R401X mutation in the NGLY1 gene S Yang, YS Cheng, R Li, M Pradhan, J Hong, J Beers, J Zou, C Liu, ... Stem cell research 39, 101496, 2019 | 2 | 2019 |
| Small-molecule high-throughput screening identifies a MEK inhibitor PD1938306 that enhances sorafenib efficacy via MCL-1 and BIM in hepatocellular carcinoma cells J Hong, W Zheng, X Cai Combinatorial chemistry & high throughput screening 26 (7), 1364, 2023 | 1 | 2023 |
| An oxidative stress response gene model for the prediction of prognosis and therapeutic responses in hepatocellular carcinoma X Cai, J Hong | 1 | 2022 |
| iPS-derived neural stem cells for disease modeling and evaluation of therapeutics for mucopolysaccharidosis type II (vol 412, 113007, 2022) J Hong, YS Cheng, S Yang, M Swaroop, M Xu, J Beers, J Zou, W Huang, ... EXPERIMENTAL CELL RESEARCH 433 (2), 2023 | | 2023 |
| Corrigendum to" iPS-derived neural stem cells for disease modeling and evaluation of therapeutics for mucopolysaccharidosis type II"[Exp. Cell Res. 412, Issue 1, 1 March 2022 … J Hong, YS Cheng, S Yang, M Swaroop, M Xu, J Beers, J Zou, W Huang, ... Experimental cell research 433 (2), 113808, 2023 | | 2023 |
| Construction of a Novel Oxidative Stress Response‐Related Gene Signature for Predicting the Prognosis and Therapeutic Responses in Hepatocellular Carcinoma J Hong, X Cai Disease Markers 2022 (1), 6201987, 2022 | | 2022 |
